MORE►
Nanoscope Therapeutics
Troy Short is senior vice president of manufacturing and supply chain at Nanoscope Therapeutics. [Photo: Nanoscope Therapeutics]
Dallas’ Nanoscope Therapeutics Taps Gene Therapy Veteran to Lead Manufacturing, Supply Chain
by Sandra Engelland | Oct 15, 2026
Troy Short joins Nanoscope as the company prepares for the launch of Mogenry, its gene therapy for severe retinitis pigmentosa, a group of eye diseases that damage the retina.
Patented: Nanoscope Instruments’ Low-Vision Function Test and 134 More Inventions Across North Texas
by Dave Head |
Sep 2, 2026
Dallas-Fort Worth ranked No. 9 among 250 U.S. metros in patent production for the week of Aug. 11, with 135 patents granted to inventors and companies across the region.
MORE►
by Sandra Engelland |
Apr 2, 2026
Paul Hallen will oversee Nanoscope's global operations, including commercial readiness, supply chain, and cross-functional execution, as the company works toward regulatory approval and launch of MCO-010 (MOGENRY), a therapy developed to treat retinitis pigmentosa.
MORE►
by Dallas Innovates | Staff Report |
Dec 10, 2025
Dallas-Fort Worth ranked No. 9 for patent activity out of 250 metros for the week of Nov. 4 with a total of 156 patents granted.
MORE►
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
Dallas’ Nanoscope Therapeutics Hires Chief Technology, Manufacturing Officer
by Lance Murray | Dec 6, 2024
Ray Kaczmarek—the former CEO of Genezen—is an expert in gene therapy manufacturing with decades of experience leading operations, technology, and commercial supply strategies at pharmaceutical and biotech companies, Nanoscope said.
MORE►
by Lance Murray |
Oct 27, 2023
Najam Sharif, Ph.D., DSc, has been appointed as vice president of global research and development by Dallas-based Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases.
Sharif is a veteran in drug/device discovery and development, the company said.
“We are delighted to welcome Naj to the Nanoscope team,” Sulagna Bhattacharya, co-founder and CEO of Nanoscope, said in a statement....
MORE►
by Dallas Innovates | Staff Report |
Apr 4, 2023
Dr. Zajicek and three other local biotech leaders—Sulagna Bhattacharya, CEO of Nanoscope Therapeutics; Gabby Everett, director of business operations and strategy at BioLabs Pegasus Park; and R.A. Session II, founder of Taysha Gene Therapies—discussed Dallas' biotech boom on a panel hosted by D CEO Healthcare.
MORE►
by Quincy Preston |
Mar 16, 2023
These standouts—startup founders, tech pioneers, educators, creators, social innovators, and business leaders—are transforming entire industries and making waves in their respective fields.
MORE►
Left: LinedanceAI co-founder Mohamed Elwazer; Center illustration: leonello/iStock; Right: Lantern Pharma CEO Panna Sharma
16 Biotech Companies in Dallas-Fort Worth ‘Putting the Tech in Bio’ to Drive Breakthroughs
by Dallas Innovates | Staff Report | Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem. Leaders in the industry attribute this success to the unique convergence of the region’s exceptional tech talent pool and cutting-edge developments in life science....
MORE►
by Lance Murray |
Jan 11, 2023
Nanoscope Therapeutics Inc., a Dallas-based clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, has appointed Massoud Motamed, Ph.D., as vice president of quality.
Motamed brings nearly a decade of CGMP quality and compliance experience, including extensive experience in manufacturing and regulatory review of gene therapy products....
MORE►
by Lance Murray |
Nov 11, 2022
Dallas-based Nanoscope Therapeutics is developing therapies that could restore sight in patients. The company also recently announced a new gene therapy manufacturing partnership.
MORE►
by Kevin Cummings |
Oct 18, 2022
Dallas-based Nanoscope Therapeutics is accelerating the development of therapies that could restore sight in patients with the help of a publicly traded firm. The retinal degenerative diseases-focused biotech company announced a new gene therapy manufacturing partnership with contract research organization Charles River Laboratories International.
MORE►
Meet the 11 Winners of the EY Entrepreneur Of The Year 2022 Central Plains Award
by Kevin Cummings | Jun 27, 2022
Ten of the 11 winners are from North Texas.
MORE►
by David Seeley |
Jun 3, 2022
In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from The DEC, American Airlines, Perimeter Medical, BRIX, NEC Corp. of America, Valor, Vizient, Apty, DHA Housing Solutions for North Texas, Southwest Airlines, Nanoscope Therapeutics, TimelyMD, and Thryv Holdings.
MORE►
by Dallas Innovates | Staff Report |
Oct 26, 2021
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
MORE►
by Alex Edwards |
Sep 14, 2021
The Bedford-based biotech will use the capital from the National Eye Institute of the National Institutes of Health to advance its gene therapy that treats age-related macular degeneration.
Earlier this summer, Nanoscope Therapeutics announced it successfully treated 11 patients who were blinded by advanced retinitis pigmentosa.
Earlier this summer, Nanoscope Therapeutics announced it successfully treated 11 patients who were blinded by advanced retinitis pigmentosa.
MORE►
